Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

Gökbuget, Nicola, Zugmaier, Gerhard, Klinger, Matthias, Kufer, Peter, Stelljes, Matthias, Viardot, Andreas, Horst, Heinz A., Neumann, Svenja, Brüggemann, Monika, Ottmann, Oliver ORCID: https://orcid.org/0000-0001-9559-1330, Burmeister, Thomas, Wessiepe, Dorothea, Topp, Max S. and Bargou, Ralf 2017. Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia. Haematologica 102 (4) , e132-e135. 10.3324/haematol.2016.153957

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (926kB) | Preview

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Ferrata Storti Foundation
ISSN:	0390-6078
Date of First Compliant Deposit:	16 May 2017
Date of Acceptance:	12 January 2017
Last Modified:	17 May 2023 06:52
URI:	https://orca.cardiff.ac.uk/id/eprint/100632

Citation Data

Cited 59 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item